Sfoglia per Autore  NAPOLI, CRISTINA

Opzioni
Mostrati risultati da 1 a 20 di 40
Titolo Data di pubblicazione Autore(i) File
Marked variation thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression in human colorectal cancer 1998 Mini E, Biondi C, Morganti M, Napoli C, Mazzoni P, Cianchi F, Rossi S, Tonelli F, Cortesini C, Mazzei T
Quantitation of intratumoral thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression by the Polymerase Chain Reaction (PCR): marked variation among human colorectal cancer patients 1998 Biondi C, Morganti M, Napoli C, Mazzoni P, Cianchi F, Rossi S, Tonelli F, Cortesini C, Mazzei T, Mini E
Molecular analysis of the FHIT gene in human sporadic colon cancers. 1999 Luceri C, De Filippo C, Caderni G, Mini E, Napoli C, Tonelli F, Cortesini C, Dolara P
Preliminary results of thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression analysis by polymerase chain reaction (PCR) in gastric cancer patients (PTS) 2000 Napoli C.; Morganti P.; Bruno L.; Nobili S.; Cortesini C.; Mazzei T.; Mini E
Expression of thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) genes by polymerase chain reaction (PCR) in gastric cancer patients (PTS): preliminary results 2000 Napoli C.; Morganti M.; Bruno L.; Nobili S.; Cortesini C.; Mazzei T.; Mini E
The role of thymidylate synthase (TS) expression in prognosis and outcome of 5-fluorouracil (5-FU)-based chemotherapy in patients (pts) with colorectal cancer (CC) 2002 Mini E.; Morganti M.; Napoli C.; Valanzano R.; Cianchi F.; Messerini A; Nobili S; Boddi V; Tonelli F; Cortesini C; Toffoli G; Mazzei T
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 2003 Landini I; Carotti S; Caciagli B; Morganti M; Napoli C; Nobili S; Giglioni B; Boddi V; Mazzei T; Mini E
Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT) 2003 Morganti M; Ciantelli M; Giglioni B; Nobili S.; Papi L.; Landini I.; Napoli C.; Valanzano R.; Cianchi F; Boddi V.; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 2004 Morganti, M; Ciantelli, M; Giglioni, B; Putignano, Al; Nobili, S; Papi, L; Landini, I; Napoli, C; Valanzano, R; Cianchi, F; Boddi, V; Tonelli, F; Cortesini, C; Mazzei, T; Genuardi, M; Mini, E.
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 2004 Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E.
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. 2004 Morganti M, Ciantelli M, Giglioni B, Putignano AL, Nobili S, Papi L, Landini I, Napoli C, Valanzano R, Cianchi F, Boddi V, Tonelli F, Cortesini C, Mazzei T, Genuardi M, Mini E
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 2005 Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 2008 Landini I, Napoli C, Nobili S, Morganti M, Rigacci L, Bosi A, Mini E
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 2008 Napoli C, Nobili S, Morganti M, Landini I, Cianchi F, Valanzano R, Tonelli F, Mazzei T, Mini E
Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles 2008 Luceri C, Castagnini C, Bigagli E, Toti S, Landini I, Napoli C, Nobili S, Mini E, Dolara P
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 2008 Landini I; Napoli C; Nobili S; Morganti M; Rigacci L; Bosi A; Mini E
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 2009 Mini E; Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Mazzei T.
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 2010 Napoli C; Nobili S; Landini I; Perrone G; Puccini B; Antognoli G; Doria M; Martelli M; Finolezzi E; Rigacci L; Di Lollo S; Bosi A; Mini E
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 2011 Napoli C; Nobili S; Landini I; Perrone G; Valenti A; Brugia M; Puccini B; Antognoli G; Doria M; Martelli M; Finolezzi E; Rigacci L; Di Lollo S; Bosi A; Mini E
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 2011 Crea F; Nobili S; Paolicchi E; Perrone G; Napoli C; Landini I; Danesi R; Mini E
Mostrati risultati da 1 a 20 di 40
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile